Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Intangibles (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Intangibles over the past 15 years, most recently at $4.2 million for Q2 2025.

  • Quarterly results put Intangibles at $4.2 million for Q2 2025, changed 0.0% from a year ago — trailing twelve months through May 2025 was $4.2 million (changed 0.0% YoY), and the annual figure for FY2025 was $4.2 million, changed 0.0%.
  • Intangibles for Q2 2025 was $4.2 million at Lifecore Biomedical, Inc. \De\, roughly flat from $4.2 million in the prior quarter.
  • Over the last five years, Intangibles for LFCR hit a ceiling of $4.2 million in Q1 2021 and a floor of $4.2 million in Q1 2021.
  • Median Intangibles over the past 5 years was $4.2 million (2021), compared with a mean of $4.2 million.
  • Peak annual rise in Intangibles hit 0.0% in 2021, while the deepest fall reached 83.42% in 2021.
  • Lifecore Biomedical, Inc. \De\'s Intangibles stood at $4.2 million in 2021, then changed by 0.0% to $4.2 million in 2022, then changed by 0.0% to $4.2 million in 2023, then changed by 0.0% to $4.2 million in 2024, then changed by 0.0% to $4.2 million in 2025.
  • The last three reported values for Intangibles were $4.2 million (Q2 2025), $4.2 million (Q1 2025), and $4.2 million (Q4 2024) per Business Quant data.